We evaluated the role of GDF11 in healthy conditions and in the transition from non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH). This evidence concerns the gene GDF11 and metabolic dysfunction-associated steatohepatitis.